Minneapolis Clinic of Neurology – Trademark Portfolio
Entity Type: 03
Minneapolis Clinic of Neurology holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SCHAPIRO CENTER FOR MULTIPLE SCLEROSIS. The owner is based in Golden Valley, MN.
4225 Golden Valley Road
Golden Valley, MN 55422
Showing of trademarks Trademarks
Trademark Classifications
Minneapolis Clinic of Neurology's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Minneapolis Clinic of Neurology have?
Minneapolis Clinic of Neurology has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Minneapolis Clinic of Neurology file in?
Minneapolis Clinic of Neurology files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Minneapolis Clinic of Neurology's most well-known trademarks?
Minneapolis Clinic of Neurology's registered trademark portfolio includes well-known marks such as SCHAPIRO CENTER FOR MULTIPLE SCLEROSIS. These are among 1 currently registered trademark in the portfolio.
What is Minneapolis Clinic of Neurology's trademark registration success rate?
Minneapolis Clinic of Neurology has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.